outcome of board meeting 14.05.2026

Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.5%Reaction day

₹109.99

prior close

₹111.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+5.2% vs market

Specialty Chemicals peers, median of 92sector+0.5%+5.0% vs sector

On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 5.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.4

10m

+6.3

15m

+5.4

30m

+4.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.5+0.2+5.2+0.5+5.0

Next day

+9.3-0.1+9.4-0.1+9.4

+7.7-1.5+9.2-1.6+9.3

+16.4-1.0+17.4-0.6+17.0

+21.3-0.4+21.7-0.9+22.2

+19.2+0.6+18.5-0.3+19.5

+15.8+2.3+13.4+1.2+14.6

15d

+17.3+3.5+13.9-0.2+17.5

+20.0+5.6+14.4-0.2+20.2

+21.8+9.5+12.3+1.7+20.2

+54.6+13.3+41.3+6.5+48.0

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 92Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Resonance Specialties Limited reported strong full-year results for FY26 ending March 2026. Revenue from operations grew 16% to Rs. 9,024.75 lakhs from Rs. 7,780.66 lakhs in FY25. Profit after tax increased significantly by 58.3% to Rs. 1,039.58 lakhs compared to Rs. 656.62 lakhs in the previous year. EPS improved from Rs. 5.69 to Rs. 9.01 per share. The Board recommended a dividend of Rs. 1 per share (10%) for FY25-26. Geographically, India revenue declined from Rs. 4,369.58 lakhs to Rs. 3,669.69 lakhs while overseas revenue grew substantially from Rs. 3,411.08 lakhs to Rs. 5,355.06 lakhs. Statutory auditors Kailash Chand Jain & Co. were reappointed for another 5-year term and issued an unmodified opinion on the financial statements.

Likely market impact

Strong PAT growth of 58% and improved EPS signal healthy profitability. The shift to export-led growth and dividend declaration are positive for shareholders. Clean audit with unmodified opinion adds credibility.